Next Article in Journal
Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data
Next Article in Special Issue
Epstein–Barr Infection, Hodgkin’s Lymphoma, and the Immune System: Insights into the Molecular Mechanisms Facilitating Immune Evasion
Previous Article in Journal
Personalization of Cancer Treatment: Exploring the Role of Chronotherapy in Immune Checkpoint Inhibitor Efficacy
 
 
cancers-logo
Article Menu

Article Menu

Article

Article Versions Notes

Cancers 2025, 17(5), 733; https://doi.org/10.3390/cancers17050733
Action Date Notes Link
article xml file uploaded 21 February 2025 12:30 CET Original file -
article xml uploaded. 21 February 2025 12:30 CET Update https://www.mdpi.com/2072-6694/17/5/733/xml
article pdf uploaded. 21 February 2025 12:30 CET Version of Record https://www.mdpi.com/2072-6694/17/5/733/pdf
article html file updated 21 February 2025 12:32 CET Original file https://www.mdpi.com/2072-6694/17/5/733/html
Back to TopTop